Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors (Q34534285)

2 August 2017

1 reference

title

Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

John Nemunaitis

1

1 reference

2 August 2017

John O'Brien

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

177-185

1 reference

2 August 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

RNA virus vectors: where are we and where do we need to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Recent advances in the application of gene therapy to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

The promise and potential hazards of adenovirus gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Targeting of adenoviral vectors through a bispecific single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Use of a novel cross-linking method to modify adenovirus tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Gene expression from adeno-associated virus vectors in airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug-resistant colon-adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Strength and specificity of different gene promoters in oral cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Vargula hilgendorfii luciferase: a secreted reporter enzyme for monitoring gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Corneal epithelium-specific mouse keratin K12 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Adenoviruses in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Simultaneous Administration of Live, Enteric-Coated Adenovirus Types 4,7, and 21 Vaccines: Safety and Immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Human adenovirus cloning vectors based on infectious bacterial plasmids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Role of early genes in pathogenesis of adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.2.177

21 January 2018

Identifiers

DOI

10.1517/14712598.2.2.177

1 reference

2 August 2017

1 reference